ArticleBMC cancer2023

Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study.

Xinlong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.